FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications Post author:Sam Post published:May 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca PLC Hits Milestone With Approval of Potential Bladder Cancer Blockbuster May 1, 2017 Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial February 5, 2018 InDex Pharmaceuticals AB Appoints New CFO March 7, 2017